Rare Dual-Mutation GIST Responds to Targeted Therapy, Challenging Established Tumor Biology
May 6, 2026
Gastrointestinal stromal tumors (GISTs) are molecularly defined by oncogenic alterations that predict clinical behavior and response to therapy.”BUFFALO, NY - May 6, 2026 – A new case report was published in... read more
